Laboratory Considerations for Clinical Trials
Science:Life Sciences
Becoming bilingual in bioanalysis
view more
In this podcast Barry Jones (Director, LC–MS Biologics and Biomarkers at Q² Solutions) and Adriane Spytko (Manager, LC–MS Biologics at Q² Solutions; both NY, USA) discuss hybrid assays using both LBA and LC−MS techniques. They share their thoughts on bottom-up LC−MS methods and the concern about detecting analyte that is not intact as well as future projects that bridge LC−MS and LBA.
More Episodes
What is the Role of Digital Pathology in Clinical Trials
2023-11-17
223
2023-11-17
223
Flexible Approaches for Biotech Companies in Clinical Trials
2022-06-22
292
2022-06-22
292
Risk Management for Biotech Companies in Clinical Trials
2022-05-16
225
2022-05-16
225
Managing Sample Data from Vendors
2021-09-14
258
2021-09-14
258
Automation within an ADME Laboratory
2021-08-26
216
2021-08-26
216
Bioanalytical Automation of Samples
2021-07-30
191
2021-07-30
191
Consent Tracking for Clinical Samples
2021-07-28
193
2021-07-28
193
Tracking Clinical Trial Samples
2021-07-28
184
2021-07-28
184
Avoiding Canceled Tests in Pediatric Samples
2021-02-02
150
2021-02-02
150
Covid Vaccine Testing
2020-09-15
200
2020-09-15
200
Hybrid Assays for Protein Bioanalysis
2020-07-29
164
2020-07-29
164
High Throughput ADME Testing
2020-07-29
106
2020-07-29
106
Liquid Biopsy Collection in Clinical Development Programs
2020-07-29
151
2020-07-29
151
Get this podcast on your
phone, FREE
